Comparing two methods for creating vascular access for kidney dialysis
Comparing surgical and endovascular arteriovenous fistula creation
This study is looking at two ways to create a special connection in your blood vessels that helps people with kidney disease get dialysis, comparing traditional surgery with a newer method to see which one works better and is safer for you.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Los Angeles NIH-funded |
| Lab location | 1 site (Los Angeles, United States) |
| Project ID | NIH-10709628 on NIH RePORTER |
What this research studies
This research investigates the outcomes of two different techniques for creating arteriovenous fistulas (AVFs), which are essential for patients undergoing hemodialysis due to end-stage kidney disease. One technique is traditional surgery, while the other is a newer endovascular method. The study aims to gather data on the effectiveness and safety of these methods to help inform future treatment decisions for patients. By comparing the procedural outcomes, the research seeks to identify which method may provide better results for patients requiring vascular access.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with end-stage kidney disease who require hemodialysis and need vascular access.
Not a fit: Patients who are not candidates for either surgical or endovascular arteriovenous fistula creation may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved vascular access options for patients on hemodialysis, potentially enhancing their treatment outcomes and quality of life.
How similar studies have performed: While there have been small-scale studies on endovascular techniques, this research aims to provide the first comprehensive comparison of endoAVF and surgAVF outcomes, making it a novel approach.
Where this research is happening
Los Angeles, United States
- University of California Los Angeles — Los Angeles, United States (Active)
Researchers
- Principal investigator: Woo, Karen — University of California Los Angeles
- Study coordinator: Woo, Karen
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.